+ -Text Size

Farhad Islami Gomeshtapeh, MD, PhD

Strategic Director, Cancer Surveillance Research


Farhad Islami, MD PhD, Strategic Director of Cancer Surveillance Research, joined the American Cancer Society (ACS) in 2014. His work is mainly on monitoring and describing trends in cancer incidence, mortality, and survival rates in the United States and worldwide by sociodemographic factors to measure progress against cancer and to formulate etiologic hypotheses. He also conducts and collaborates on research focused on cancer disparities and cancer risk factors, in particular tobacco smoking.

Dr. Islami earned a M.D. from Tehran University of Medical Sciences in 1994, and a Ph.D. in Epidemiology from King’s College London in 2010. He completed a post-doctoral fellowship in the International Agency for Research on Cancer (the cancer research agency of the World Health Organization), in Lyon, France. He was a faculty member at the Icahn School of Medicine at Mount Sinai, New York, before joining ACS. Dr. Islami is the author or coauthor of more than 110 articles published in peer reviewed journals, several book chapters, and the Tobacco Atlas, 5th Edition.